直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

We share our Insights on a regular basis.

Media Contacts
Terra Liddell
Chief Marketing Officer
Washington, DC
Email
Angela Robinson
Director of Branding and Communications
Washington, DC
Email

IP Updates

Unified Patent Court (UPC) Hub

2026

Articles

Preempting Surprise Injunctions in Germany and the UPC: Strategic Use of the Schutzschrift in Global Patent Litigation 

March 27, 2026

Articles

Patent Ruling Shows Quiet Power of State-Law Bad-Faith Statutes

February 20, 2026

Articles

EPR Academy, Part 2 of 6: The EPR Process – From Request to Reexamination Certificate

December 5, 2025

IP Updates

Tenth Circuit Sides with Netflix in Tiger King Copyright Challenge 

May 5, 2026

IP Updates

PIER Pilot Program - Synopsis

IP Updates

White House Releases National AI Legislative Framework

March 23, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

INCONTESTABLE® Blog

Supreme Court Recalibrates Contributory Copyright Liability

March 30, 2026

Never miss an Insight.

Sign up

Recent Insights

to

Articles

A Look at Ex Parte Seizures 8 Years Post-DTSA

A Look at Ex Parte Seizures 8 Years Post-DTSA A Look at Ex Parte Seizures 8 Years Post-DTSA

April 17, 2024

Law360

Articles

Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation

Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation Potential Implications of Inflation Reduction Act on Pharmaceutical Patent Litigation

May 1, 2023

Bloomberg Law

At the PTAB Blog

Moderna’s Appeal of PTAB Decision Dismissed for Lack of Standing Moderna’s Appeal of PTAB Decision Dismissed for Lack of Standing

December 20, 2021

Articles

Ex Parte Seizure Under the Defend Trade Secrets Act: Insights on the New Remedy Ex Parte Seizure Under the Defend Trade Secrets Act: Insights on the New Remedy

April 8, 2020

Westlaw Journal Intellectual Property

Articles

Three Years Later: How the Defend Trade Secrets Act Complicated the Law Instead of Making It More Uniform Three Years Later: How the Defend Trade Secrets Act Complicated the Law Instead of Making It More Uniform

July/August 2019

IP Litigator

Books

Coordinating New Drug Application (NDA) and Patent Portfolio Strategy Coordinating New Drug Application (NDA) and Patent Portfolio Strategy

2018

Pre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, Second Edition

Articles

Impermissibly Redefining 'Long-Felt Need' Using Hindsight

Impermissibly Redefining 'Long-Felt Need' Using Hindsight Impermissibly Redefining 'Long-Felt Need' Using Hindsight

March 2, 2018

Law360

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP